The role of matrix metalloproteinases and their tissue inhibitors in the formation of hypertrophic skin scars with the use of a pulsed dye laser and Fermencol phonophoresis

Abstract

BACKGROUND: An imbalance between matrix metalloproteinases (MMPs) expression and tissue inhibitors of MMP is considered as a possible mechanism for impaired collagen synthesis and degradation, which leads to the development of hypertrophic scars. The use of a vascular laser, in particular a pulsed dye laser, leads to coagulation of the vascular locus that feeds the hypertrophic skin scar, resulting in a decrease in extracellular matrix synthesis. The use of collagenase phonophoresis increases the effectiveness of laser therapy due to the destruction of the extracellular matrix.

AIM: To study the role of matrix metalloproteinases and their tissue inhibitors in the pathogenesis of immature hypertrophic skin scars and to evaluate the dynamics of enzymes during the combined use of a pulsed dye laser and Fermenkol phonophoresis.

MATERIAL AND METHODS: The study was performed with the participation of 125 patients aged 22 to 55 years with immature (up to 6 months) hypertrophic skin scars. All patients were divided into 4 groups according to the simple fixed randomization procedure. The first group (control, n=32) received course local compression therapy using silicone plates for 2 months. The second group (main group I, n=31) underwent two courses of Fermencol phonophoresis (5 daily procedures lasting 10 minutes each with a break of 3–4 weeks). The third group (main group II, n=31) underwent two pulsed dye laser procedures with an interval of 4 weeks. The fourth group (main III, n=31) received complex treatment, which included a combination of two pulsed dye laser procedures and two cycles of Fermenkol phonophoresis. The study of the clinical condition of patients was carried out according to the modified Vancouver scar scale (VSS). The content of MMP and tissue inhibitor of metalloproteinase-1 in blood serum was determined by enzyme immunoassay. Patients were examined twice: before the start and 2 weeks after the end of the course of treatment. To form a sample of reference values of MMPs and tissue inhibitors of metalloproteinases (TIMPs), a group of 20 somatically healthy individuals was used.

RESULTS: Initially reduced levels of MMP-1 and MMP-9 were found in the blood serum of patients with immature hypertrophic skin scars, with high values of TIMP-1, which allows us to consider reduced expression as an important link in the pathogenesis of the fibroproliferative process in the skin, which causes excessive deposition of extracellular matrix components. The use of pulsed dye laser in combination with Fermencol phonophoresis was accompanied by an increase in the content of MMP in the blood serum of patients with immature hypertrophic skin scars, which positively correlated with the severity of the clinical result of treatment, assessed by VSS.

CONCLUSION: A conclusion was made about the clinical and pathogenetic significance of MMPs and TIMPs in the development of fibroplastic processes, which allows us to consider these biochemical parameters as informative criteria for the effectiveness of the therapy.

Keywords

matrix metalloproteinases / pulsed dye laser / immature hypertrophic skin scars / phonophoresis / Fermencol / tissue inhibitor of metalloproteinases / Vancouver skin scar rating scale

References

[1] Talybova AP, Stenko AG, Korchazhkina NB. Innovative physiotherapeutic technologies in the treatment of combined scarring of the skin. Physiotherapist. 2017;(1):47–55. (In Russ).

[2] Талыбова А.П., Стенько А.Г., Корчажкина Н.Б. Инновационные физиотерапевтические технологии в лечении комбинированных рубцовых изменений кожи // Физиотерапевт. 2017. № 1. С. 47–55.

[3] Shi JH, Guan H, Shi S, et al. Protection against TGF-beta1-induced fibrosis effects of IL-10 on dermal fibroblasts and its potential therapeutics for the reduction of skin scarring. Arch Dermatol Res. 2013;305(4):341–352. doi: 10.1007/s00403-013-1314-0

[4] Shi J.H., Guan H., Shi S., et al. Protection against TGF-beta1-induced fibrosis effects of IL-10 on dermal fibroblasts and its potential therapeutics for the reduction of skin scarring // Arch Dermatol Res. 2013. Vol. 305, N 4. Р. 341–352. doi: 10.1007/s00403-013-1314-0

[5] Manturova NE, Kruglova LS, Stenko AG. Skin scars: Clinical manifestations, diagnosis and treatment. Moscow: GEOTAR-Media; 2021. 208 p. (In Russ).

[6] Мантурова Н.Е., Круглова Л.С., Стенько А.Г. Рубцы кожи: клинические проявления, диагностика и лечение. Москва: ГЭОТАР-Медиа, 2021. 208 с.

[7] Yuan B, Upton Z, Leavesley D, et al. Vascular and collagen target: A rational approach to hypertrophic scar management. Adv Wound Care (New Rochelle). 2023;12(1):38–55. doi: 10.1089/wound.2020.1348

[8] Yuan B., Upton Z., Leavesley D., et al. Vascular and collagen target: A rational approach to hypertrophic scar management // Adv Wound Care (New Rochelle). 2023. Vol. 12, N 1. P. 38–55. doi: 10.1089/wound.2020.1348

[9] Lee DE, Trowbridge RM, Ayoub NT, et al. High-mobility group box protein-1, matrix metalloproteinases, and vitamin D in keloids and hypertrophic scars. Plast Reconstr Surg Glob Open. 2015;3(6):e425. doi: 10.1097/GOX.0000000000000391

[10] Lee D.E., Trowbridge R.M., Ayoub N.T., et al. High-mobility group box protein-1, matrix metalloproteinases, and vitamin D in keloids and hypertrophic scars // Plast Reconstr Surg Glob Open. 2015. Vol. 3, N 6. P. e425. doi: 10.1097/GOX.0000000000000391

[11] Simon F, Bergeron D, Larochelle S, et al. Enhanced secretion of TIMP-1 by human hypertrophic scar keratinocytes could contribute to fibrosis. Burns. 2012;38(3):421–427. doi: 10.1016/j.burns.2011.09.001

[12] Simon F., Bergeron D., Larochelle S., et al. Enhanced secretion of TIMP-1 by human hypertrophic scar keratinocytes could contribute to fibrosis // Burns. 2012. Vol. 38, N 3. P. 421–427. doi: 10.1016/j.burns.2011.09.001

[13] Ulrich D, Ulrich F, Unglaub F, et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids. J Plast Reconstr Aesthet Surg. 2010;63(6):1015–1021. doi: 10.1016/j.bjps.2009.04.021

[14] Ulrich D., Ulrich F., Unglaub F., et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids // J Plast Reconstr Aesthet Surg. 2010. Vol. 63, N 6. P. 1015–1021. doi: 10.1016/j.bjps.2009.04.021

[15] Zhang S, Zhao ZM, Xue HY, Nie FF. Effects of photoelectric therapy on proliferation and apoptosis of scar cells by regulating the expression of microRNA-206 and its related mechanisms. Int Wound J. 2020;17(2):317–325. doi: 10.1111/iwj.13272

[16] Zhang S., Zhao Z.M., Xue H.Y., Nie F.F. Effects of photoelectric therapy on proliferation and apoptosis of scar cells by regulating the expression of microRNA-206 and its related mechanisms // Int Wound J. 2020. Vol. 17, N 2. P. 317–325. doi: 10.1111/iwj.13272

[17] Yarmolinskaya MI, Molotkov AS, Denisov VM. Matrix metalloproteinases and inhibitors: Classification, mechanism of action. J Obstetrics Women's Diseases. 2012;61(1):113–125. (In Russ).

[18] Ярмолинская М.И., Молотков А.С., Денисова В.М. Матриксные металлопротеиназы и ингибиторы: классификация, механизм действия // Журнал акушерства и женских болезней. 2012. Т. 61, № 1. С. 113–125.

[19] Kuo YR, Jeng SF, Wang FS, et al. Flashlamp pulsed dye laser (PDL) suppression of keloid proliferation through down-regulation of TGF-beta1 expression and extracellular matrix expression. Lasers Surg Med. 2004;34(2):104–108. doi: 10.1002/lsm.10206

[20] Kuo Y.R., Jeng S.F., Wang F.S., et al. Flashlamp pulsed dye laser (PDL) suppression of keloid proliferation through down-regulation of TGF-beta1 expression and extracellular matrix expression // Lasers Surg Med. 2004. Vol. 34, N 2. Р. 104–108. doi: 10.1002/lsm.10206

[21] Allison KP, Kiernan MN, Waters RA, Clement RM. Pulsed dye laser treatment of burn scars. Alleviation or irritation? Burns. 2003;29(3):207–213. doi: 10.1016/s0305-4179(02)00280-2

[22] Allison K.P., Kiernan M.N., Waters R.A., Clement R.M. Pulsed dye laser treatment of burn scars. Alleviation or irritation? // Burns. 2003. Vol. 29, N 3. P. 207–213. doi: 10.1016/s0305-4179(02)00280-2

[23] Dierickx CC, Casparian JM, Venugopalan V, et al. Thermal relaxation of port-wine stain vessels probed in vivo: The need for 1-10-millisecond laser pulse treatment. J Invest Dermatol. 1995;105(5):709–714. doi: 10.1111/1523-1747.ep12324514

[24] Dierickx C.C., Casparian J.M., Venugopalan V., et al. Thermal relaxation of port-wine stain vessels probed in vivo: The need for 1-10-millisecond laser pulse treatment // J Invest Dermatol. 1995. Vol. 105, N 5. Р. 709–714. doi: 10.1111/1523-1747.ep12324514

[25] Pandia [Internet]. Clinical protocol for the diagnosis and treatment of patients with scarred skin lesions. (In Russ). Available from: https://pandia.ru/text/80/521/21751.php. Accessed: 15.12.2022.

[26] Pandia [интернет]. Клинический протокол по диагностике и лечению пациентов с рубцовыми поражениями кожи. Режим доступа: https://pandia.ru/text/80/521/21751.php. Дата обращения: 15.12.2022.

[27] Shakina LD, Ponomarev IV, Smirnov IE. Laser surgery of vascular skin tumors in young children. Russian Pediatric Journal. 2019;22(2):99–105. (In Russ). doi: 10.18821/1560-9561-2019-22-2-99-105

[28] Шакина Л.Д., Пономарев И.В., Смирнов И.Е. Лазерная хирургия сосудистых опухолей кожи у детей раннего возраста // Российский педиатрический журнал. 2019. Т. 22, № 2. С. 99–105. doi: 10.18821/1560-9561-2019-22-2-99-105

[29] Grigorkevich OS, Mokrov GV, Kosova LYu. Matrix metalloproteinases and their inhibitors. Pharmacokinetics Pharmacodynamics. 2019;(2):3–16. (In Russ). doi: 10.24411/2587-7836-2019-10040

[30] Григоркевич О.С., Мокров Г.В., Косова Л.Ю. Матриксные металлопротеиназы и их ингибиторы // Фармакокинетика и фармакодинамика. 2019. № 2. С. 3–16. doi: 10.24411/2587-7836-2019-10040

[31] Markelova EV, Zdorov VV, Romanchuk AL, et al. Matrix metalloproteinases: Their relationship with the cytokine system, diagnostic and prognostic potential. Immunopathology, Allergology, Infectology. 2016;(2):11–22. (In Russ).

[32] Маркелова Е.В., Здор В.В., Романчук А.Л., и др. Матриксные металлопротеиназы: их взаимосвязь с системой цитокинов, диагностический и прогностический потенциал // Иммунопатология, аллергология, инфектология. 2016. № 2. С. 11–22.

[33] Shadrina AS, Plieva YaZ, Kushlinsky DN, et al. Classification, regulation of activity, genetic polymorphism of matrix metalloproteinases in norm and pathology. Almanac Clinical Medicine. 2017;45(4):266–279. (In Russ). doi: 10.18786/2072-0505-2017-45-4-266-279

[34] Шадрина А.С., Плиева Я.З., Кушлинский Д.Н., и др. Классификация, регуляция активности, генетический полиморфизм матриксных металлопротеиназ в норме и при патологии // Альманах клинической медицины. 2017. Т. 45, № 4. С. 266–279. doi: 10.18786/2072-0505-2017-45-4-266-279

[35] Davis GE, Saunders WB. Molecular balance of capillary tube formation versus regression in wound repair: Role of matrix metalloproteinases and their inhibitors. J Investig Dermatol Symp Proc. 2006;11(1):44–56. doi: 10.1038/sj.jidsymp.5650008

[36] Davis G.E., Saunders W.B. Molecular balance of capillary tube formation versus regression in wound repair: Role of matrix metalloproteinases and their inhibitors // J Investig Dermatol Symp Proc. 2006. Vol. 11, N 1. P. 44–56. doi: 10.1038/sj.jidsymp.5650008

[37] Saunders WB, Bayless KJ, Davis GE. MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices. J Cell Sci. 2005;118(Pt. 10):2325–2340. doi: 10.1242/jcs.02360

[38] Saunders W.B., Bayless K.J., Davis G.E. MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices // J Cell Sci. 2005. Vol. 118, Pt. 10. P. 2325–2340. doi: 10.1242/jcs.02360

[39] Álvares PR, Arruda JA, Silva LP, et al. Immunohistochemical expression of TGF-β1 and MMP-9 in periapical lesions. Braz Oral Res. 2017;31:e51. doi: 10.1590/1807-3107BOR-2017

[40] Álvares P.R., Arruda J.A., Silva L.P., et al. Immunohistochemical expression of TGF-β1 and MMP-9 in periapical lesions // Braz Oral Res. 2017. Vol. 31. Р. e51. doi: 10.1590/1807-3107BOR-2017

[41] Lucas BR, Voegels RL, do Amaral JB, et al. BMP-7, MMP-9, and TGF-β tissue remodeling proteins and their correlations with interleukins 6 and 10 in chronic rhinosinusitis. Eur Arch Otorhinolaryngol. 2021;278(11):4335–4343. doi: 10.1007/s00405-021-06722-8

[42] Lucas B.R., Voegels R.L., do Amaral J.B., et al. BMP-7, MMP-9, and TGF-β tissue remodeling proteins and their correlations with interleukins 6 and 10 in chronic rhinosinusitis // Eur Arch Otorhinolaryngol. 2021. Vol. 278, N 11. P. 4335–4343. doi: 10.1007/s00405-021-06722-8

[43] Lesnichenko IF, Gritsaev CV, Kapustin SI. Matrix metallоproteinases: Characteristics, role in leukogenesis and prognostic value. Problems Oncology. 2011;57(3):286–294. (In Russ).

[44] Лесниченко И.Ф., Грицаев C.В., Капустин С.И. Матриксные металлопротеиназы: характеристика, роль в лейкозогенезе и прогностическое значение // Вопросы онкологии. 2011. Т. 57, № 3. С. 286–294.

[45] Obraztsova AE, Nozdrevatykh AA. Morphofunctional features of the reparative process in the healing of skin wounds, taking into account possible scar deformities (literature review). Bulletin New Medical Technologies. Electronic edition. 2021;(1):98–107. (In Russ). doi: 10.24412/2075-4094-2021-1-3-3

[46] Образцова А.Е., Ноздреватых А.А. Морфофункциональные особенности репаративного процесса при заживлении кожных ран с учетом возможных рубцовых деформаций (обзор литературы) // Вестник новых медицинских технологий. Электронное издание. 2021. № 1. С. 98–107. doi: 10.24412/2075-4094-2021-1-3-3

[47] Kuo YR, Wu WS, Jeng SF, et al. Activation of ERK and p38 kinase mediated keloid fibroblast apoptosis after flashlamp pulsed-dye laser treatment. Lasers Surg Med. 2005;36(1):31–37. doi: 10.1002/lsm.20129

[48] Kuo Y.R., Wu W.S., Jeng S.F., et al. Activation of ERK and p38 kinase mediated keloid fibroblast apoptosis after flashlamp pulsed-dye laser treatment // Lasers Surg Med. 2005. Vol. 36, N 1. P. 31–37. doi: 10.1002/lsm.20129

[49] Kuo YR, Wu WS, Jeng SF, et al. Suppressed TGF-beta1 expression is correlated with up-regulation of matrix metalloproteinase-13 in keloid regression after flashlamp pulsed-dye laser treatment. Lasers Surg Med. 2005;36(1):38–42. doi: 10.1002/lsm.20104

[50] Kuo Y.R., Wu W.S., Jeng S.F., et al. Suppressed TGF-beta1 expression is correlated with up-regulation of matrix metalloproteinase-13 in keloid regression after flashlamp pulsed-dye laser treatment // Lasers Surg Med. 2005. Vol. 36, N 1. Р. 38–42. doi: 10.1002/lsm.20104

[51] Basso FG, Soares DG, Pansani TN, et al. Proliferation, migration, and expression of oral-mucosal-healing-related genes by oral fibroblasts receiving low-level laser therapy after inflammatory cytokines challenge. Lasers Surg Med. 2016;48(10):1006–1014. doi: 10.1002/lsm.22553

[52] Basso F.G., Soares D.G., Pansani T.N., et al. Proliferation, migration, and expression of oral-mucosal-healing-related genes by oral fibroblasts receiving low-level laser therapy after inflammatory cytokines challenge // Lasers Surg Med. 2016. Vol. 48, N 10. P. 1006–1014. doi: 10.1002/lsm.22553

[53] Xue M, March L, Sambrook PN, et al. Differential regulation of matrix metalloproteinase 2 and matrix metalloproteinase 9 by activated protein C: Relevance to inflammation in rheumatoid arthritis. Arthritis Rheum. 2007;56(9):2864–2874. doi: 10.1002/art.22844

[54] Xue M., March L., Sambrook P.N., et al. Differential regulation of matrix metalloproteinase 2 and matrix metalloproteinase 9 by activated protein C: Relevance to inflammation in rheumatoid arthritis // Arthritis Rheum. 2007. Vol. 56, N 9. P. 2864–2874. doi: 10.1002/art.22844

[55] Rogova LN, Shesternina NV, Znamennik TV, Fastova IA. Matrix metalloproteinases, their role in physiological and pathological processes (review). Bulletin New Medical Technologies. 2011;18(2):86–89. (In Russ).

[56] Рогова Л.Н., Шестернина Н.В., Замечник Т.В., Фастова И.А. Матриксные металлопротеиназы, их роль в физиологических и патологических процессах (обзор) // Вестник новых медицинских технологий. 2011. Т. 18, № 2. С. 86–89.

[57] Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69(3):562–573. doi: 10.1016/j.cardiores.2005.12.002

[58] Nagase H., Visse R., Murphy G. Structure and function of matrix metalloproteinases and TIMPs // Cardiovasc Res. 2006. Vol. 69, N 3. P. 562–573. doi: 10.1016/j.cardiores.2005.12.002

RIGHTS & PERMISSIONS

Eco-Vector